BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34535664)

  • 1. A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.
    Crouchet E; Bandiera S; Fujiwara N; Li S; El Saghire H; Fernández-Vaquero M; Riedl T; Sun X; Hirschfield H; Jühling F; Zhu S; Roehlen N; Ponsolles C; Heydmann L; Saviano A; Qian T; Venkatesh A; Lupberger J; Verrier ER; Sojoodi M; Oudot MA; Duong FHT; Masia R; Wei L; Thumann C; Durand SC; González-Motos V; Heide D; Hetzer J; Nakagawa S; Ono A; Song WM; Higashi T; Sanchez R; Kim RS; Bian CB; Kiani K; Croonenborghs T; Subramanian A; Chung RT; Straub BK; Schuppan D; Ankavay M; Cocquerel L; Schaeffer E; Goossens N; Koh AP; Mahajan M; Nair VD; Gunasekaran G; Schwartz ME; Bardeesy N; Shalek AK; Rozenblatt-Rosen O; Regev A; Felli E; Pessaux P; Tanabe KK; Heikenwälder M; Schuster C; Pochet N; Zeisel MB; Fuchs BC; Hoshida Y; Baumert TF
    Nat Commun; 2021 Sep; 12(1):5525. PubMed ID: 34535664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.
    Crouchet E; Li S; Sojoodi M; Bandiera S; Fujiwara N; El Saghire H; Zhu S; Qian T; Rasha FA; Del Zompo F; Barrett SC; Schaeffer E; Oudot MA; Ponsolles C; Durand SC; Ghoshal S; Arora G; Giannone F; Chung RT; Slovic N; Van Renne N; Felli E; Pessaux P; Lupberger J; Pochet N; Schuster C; Tanabe KK; Hoshida Y; Fuchs BC; Baumert TF
    JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35801591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy.
    Dolicka D; Sobolewski C; Gjorgjieva M; Correia de Sousa M; Berthou F; De Vito C; Colin DJ; Bejuy O; Fournier M; Maeder C; Blackshear PJ; Rubbia-Brandt L; Foti M
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):597-621. PubMed ID: 32987153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation.
    Zhang W; Zhangyuan G; Wang F; Jin K; Shen H; Zhang L; Yuan X; Wang J; Zhang H; Yu W; Huang R; Xu X; Yin Y; Zhong G; Lin A; Sun B
    Immunity; 2021 Jun; 54(6):1168-1185.e8. PubMed ID: 34038747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
    Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
    Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
    Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
    J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma.
    Chen K; Li Z; Zhang M; Wang B; Peng T; Shen Y; Zhang J; Ye J; Liu Y; Tang D; Peng M; Ma D; Xiao Z; Zhang Y; Jin W; Li X
    Biomed Res Int; 2020; 2020():1964219. PubMed ID: 33083453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus.
    Takeda H; Takai A; Iguchi E; Mishima M; Arasawa S; Kumagai K; Eso Y; Shimizu T; Takahashi K; Ueda Y; Taura K; Hatano E; Iijima H; Aoyagi H; Aizaki H; Marusawa H; Wakita T; Seno H
    Carcinogenesis; 2021 May; 42(5):672-684. PubMed ID: 33617626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
    Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
    Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
    Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of the Hedgehog pathway in hepatocellular carcinoma.
    Della Corte CM; Viscardi G; Papaccio F; Esposito G; Martini G; Ciardiello D; Martinelli E; Ciardiello F; Morgillo F
    World J Gastroenterol; 2017 Jun; 23(24):4330-4340. PubMed ID: 28706416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
    Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.
    Miura K; Ishioka M; Minami S; Horie Y; Ohshima S; Goto T; Ohnishi H
    J Biol Chem; 2016 May; 291(22):11504-17. PubMed ID: 27022031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
    Fuchs BC; Hoshida Y; Fujii T; Wei L; Yamada S; Lauwers GY; McGinn CM; DePeralta DK; Chen X; Kuroda T; Lanuti M; Schmitt AD; Gupta S; Crenshaw A; Onofrio R; Taylor B; Winckler W; Bardeesy N; Caravan P; Golub TR; Tanabe KK
    Hepatology; 2014 Apr; 59(4):1577-90. PubMed ID: 24677197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC.
    Grohmann M; Wiede F; Dodd GT; Gurzov EN; Ooi GJ; Butt T; Rasmiena AA; Kaur S; Gulati T; Goh PK; Treloar AE; Archer S; Brown WA; Muller M; Watt MJ; Ohara O; McLean CA; Tiganis T
    Cell; 2018 Nov; 175(5):1289-1306.e20. PubMed ID: 30454647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection.
    Zhang DY; Goossens N; Guo J; Tsai MC; Chou HI; Altunkaynak C; Sangiovanni A; Iavarone M; Colombo M; Kobayashi M; Kumada H; Villanueva A; Llovet JM; Hoshida Y; Friedman SL
    Gut; 2016 Oct; 65(10):1754-64. PubMed ID: 26045137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.
    Cevik O; Li D; Baljinnyam E; Manvar D; Pimenta EM; Waris G; Barnes BJ; Kaushik-Basu N
    J Biol Chem; 2017 Dec; 292(52):21676-21689. PubMed ID: 29079574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia.
    Abu-Remaileh M; Khalaileh A; Pikarsky E; Aqeilan RI
    Cell Death Dis; 2018 May; 9(5):511. PubMed ID: 29724996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.